Heron Therapeutics | ARS:年度報告
04/29 14:39 (美東)
Heron Therapeutics | DEF 14A:股東委託書決議
04/29 14:38 (美東)
Heron Therapeutics | 4:持股變動聲明-高管 Duarte Ira
04/19 17:50 (美東)
Heron Therapeutics | PRE 14A:並購重組委托聲明
04/19 17:25 (美東)
Heron Therapeutics | 4:持股變動聲明-高管 Forbes William P
04/19 17:06 (美東)
Heron Therapeutics | 4:持股變動聲明-高管 Collard Craig A
04/19 16:40 (美東)
Heron Therapeutics | 4:持股變動聲明-高管 Collard Craig A
04/05 15:59 (美東)
Heron Therapeutics | 8-K:重大事件
03/21 16:38 (美東)
Heron Therapeutics | 10-K:年度報表
03/12 16:19 (美東)
Heron Therapeutics | 8-K:Heron Therapeutics公佈2023年第四季度和全年財務業績並重點介紹最近的公司最新動態
03/12 16:15 (美東)
Heron Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Baker Bros. Advisors LP(4.99%),Baker Bros. Advisors (GP) LLC(4.99%)等
02/14 17:47 (美東)
Heron Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Great Point Partners, LLC(0%),Dr. Jeffrey R. Jay, M.D.(0%)等
02/14 16:44 (美東)
Heron Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Deep Track Capital, LP(0%),Deep Track Biotechnology Master Fund, Ltd.(0%)等
02/14 08:51 (美東)
Heron Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(5.56%)
02/13 18:09 (美東)
Heron Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Franklin Resources, Inc.(4.3%)
02/06 11:47 (美東)
Heron Therapeutics | 8-K:重大事件
01/24 08:04 (美東)
Heron Therapeutics | 4:持股變動聲明-董事 Christian Waage
01/19 00:00 (美東)
Heron Therapeutics | 4:持股變動聲明-董事 Rodriguez Susan
01/19 00:00 (美東)
Heron Therapeutics | 4:持股變動聲明-董事 Morgan Adam
01/19 00:00 (美東)
Heron Therapeutics | 4:持股變動聲明-董事 Johnson Craig A
01/19 00:00 (美東)
暫無數據
暫無數據